- Report
- February 2024
- 181 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- February 2024
- 197 Pages
Global
From €3475EUR$3,600USD£2,981GBP
- Report
- September 2019
Global
From €5183EUR$5,370USD£4,446GBP
- Book
- January 2018
- 392 Pages
- Book
- April 2010
- 322 Pages
- Book
- November 2014
- 372 Pages
- Book
- October 2022
Latin America
- Book
- June 2020
- 372 Pages
- Book
- February 2019
Global
- Book
- October 2018
- 536 Pages
Global
The Obesity market is a therapeutic area that focuses on the treatment of obesity and related conditions. It includes a range of treatments, from lifestyle changes such as diet and exercise to medications and surgical interventions. The goal of these treatments is to reduce the risk of obesity-related health complications, such as type 2 diabetes, heart disease, and stroke.
The market is driven by a growing awareness of the health risks associated with obesity, as well as the increasing prevalence of the condition. Additionally, advances in medical technology have enabled more effective treatments for obesity, such as bariatric surgery.
Several companies are active in the Obesity market, including Novo Nordisk, Orexigen Therapeutics, Arena Pharmaceuticals, and Vivus. These companies are focused on developing treatments for obesity, ranging from lifestyle interventions to medications and surgical interventions. Show Less Read more